`
`UNITED STATES PATENT AND TRADEMARKOFFICE
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`HIKMA PHARMACEUTICALSUSA INC.,,
`
`HIKMA PHARMACEUTICALSPLC,
`
`Petitioner,
`
`Vv.
`
`AMARIN PHARMACEUTICALS IRELAND LIMITED,
`
`Patent Owner.
`
`PTAB CASE: IPR2022-00215
`
`Patent No. 8,642,077 B2
`
`PATENT OWNER’S POWER OF ATTORNEY
`
`
`
`Pursuant to 37 C.F.R. 42.10(b), Patent Owner, Amarin Pharmaceuticals
`
`Ireland Limited, hereby appoints the following lead and back-up counsel
`
`to
`
`transact all business before the Patent Trial and Appeal Board of the United States
`
`Patent and Trademark Office in connection with a Petition for /mter Partes Review
`
`of U.S. Patent No, 8,642,077 B2 entitled “Stable Pharmaceutical Composition and
`
`Methods of Using Same.”
`
`
`
`
`Kourtney Mueller Merrill
`USPTO Reg. No. 58,195
`
`
`Perkins Coie LLP
`
`
`1900 Sixteenth Street Suite 1400
`Denver, Colorado 80202-5255
`
`
`Phone: 303-291-2300
`
`
`Fax: 303-291-2400
`
`merrill-ptab@perkinscoie.com
`
`LEAD COUNSEL
`
`BACK-UP COUNSEL
`
`David B. Fournier
`USPTO Reg. No. 51,696
`Perkins Coie LLP
`110 North Wacker Drive, Suite 3400
`Chicago,Illinois 60606-1511
`Phone: 312-324-8400
`Fax: 312-324-9400
`fournier-ptab@perkinscoie.com
`
`
`The undersigned is authorized to sign this Power of Attorney on behalf of
`
`Patent Owner Amarin Pharmaceuticals Ireland Limited.
`
`Date: March 8, 2022
`
`beh
`Name: Darha Curys
`Title: VP, Fikeilsctuic| feoperty
`
`Amarin Pharmaceuticais Ireland Limited
`
`
`
`
`
`